SIRT6 prevent chronic cerebral hypoperfusion induced cognitive impairment by remodeling mitochondrial dynamics in a
Yong Du1, Jiaqing He2, Yanni Xu1
1Department of Neurosurgery, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, 710032, China.
Insights
Sirtuin 6 (SIRT6) protects against vascular dementia (VaD) by preventing neuronal damage caused by chronic cerebral hypoperfusion (CCH). Enhancing SIRT6 activity offers a potential therapeutic strategy for cognitive impairment in VaD patients.
Area of Science:
- Neuroscience
- Cellular Biology
- Gerontology
Background:
- Vascular dementia (VaD) is a common dementia linked to chronic cerebral hypoperfusion (CCH).
- The precise mechanisms driving VaD pathogenesis and effective treatments remain unclear.
- Sirtuin 6 (SIRT6) is involved in crucial cellular processes like metabolism, DNA repair, and aging.
Purpose of the Study:
- To investigate the role of Sirtuin 6 (SIRT6) in the context of vascular dementia (VaD) induced by chronic cerebral hypoperfusion (CCH).
- To explore SIRT6's potential as a therapeutic target for mitigating cognitive deficits associated with VaD.
Main Methods:
- Utilized a bilateral common carotid artery stenosis (BCAS) mouse model to simulate chronic cerebral hypoperfusion (CCH).
- Assessed neuronal SIRT6 protein levels following CCH.
- Examined the effects of neuron-specific Sirt6 gene ablation and SIRT6 agonist (MDL-800) treatment on neuronal damage and cognitive function.
- Investigated the molecular mechanisms involving mitochondrial dynamics and the STAT5-PGAM5-Drp1 signaling pathway.
- Correlated monocyte SIRT6 gene expression with cognitive outcomes in human patients with asymptomatic carotid stenosis.
Main Results:
- Neuronal SIRT6 protein expression significantly decreased following CCH.
- Neuron-specific Sirt6 ablation worsened neuronal damage and cognitive deficits in the VaD model.
- SIRT6 agonist treatment (MDL-800) reduced neuronal loss and improved neurological recovery.
- SIRT6 was found to inhibit excessive mitochondrial fission by suppressing the CCH-induced STAT5-PGAM5-Drp1 pathway.
- Monocyte SIRT6 expression in human patients correlated with cognitive status.
Conclusions:
- SIRT6 plays a protective role against cognitive impairment induced by chronic cerebral hypoperfusion (CCH).
- SIRT6 mitigates VaD by regulating mitochondrial dynamics via the STAT5-PGAM5-Drp1 signaling pathway.
- Targeting SIRT6 represents a promising therapeutic avenue for vascular dementia.
Abstract:
Vascular dementia (VaD) is a prevalent form of dementia resulting from chronic cerebral hypoperfusion (CCH). However, the pathogenic mechanisms of VaD and corresponding therapeutic strategies are not well understood. Sirtuin 6 (SIRT6) has been implicated in various biological processes, including cellular metabolism, DNA repair, redox homeostasis, and aging. Nevertheless, its functional relevance in VaD remains unexplored. In this study, we utilized a bilateral common carotid artery stenosis (BCAS) mouse model of VaD to investigate the role of SIRT6. We detected a significant decrease in neuronal SIRT6 protein expression following CCH. Intriguingly, neuron-specific ablation of Sirt6 in mice exacerbated neuronal damage and cognitive deficits after CCH. Conversely, treatment with MDL-800, an agonist of SIRT6, effectively mitigated neuronal loss and facilitated neurological recovery. Mechanistically, SIRT6 inhibited excessive mitochondrial fission by suppressing the CCH-induced STAT5-PGAM5-Drp1 signaling cascade. Additionally, the gene expression of monocyte SIRT6 in patients with asymptomatic carotid stenosis showed a correlation with cognitive outcomes, suggesting translational implications in human subjects. Our findings provide the first evidence that SIRT6 prevents cognitive impairment induced by CCH, and mechanistically, this protection is achieved through the remodeling of mitochondrial dynamics in a STAT5-PGAM5-Drp1-dependent manner.
Related Concept Videos
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when presynaptic neurons...


